DERMOVATE

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug DERMOVATE contains one active pharmaceutical ingredient (API):

1	Clobetasol propionate UNII 779619577M - CLOBETASOL PROPIONATE
	Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.
	Read more about Clobetasol propionate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DERMOVATE Scalp application	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AD01	Clobetasol	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AD Corticosteroids, very potent (group IV)
Discover more medicines within D07AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02213265, 02213273, 02213281
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	09403981, 09403998, 15398385, 15398391
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.363-03-02, 24.642-08-02
EE	Ravimiamet	1005208, 1005242, 1005286, 1829325, 1842386
GB	Medicines & Healthcare Products Regulatory Agency	138631, 142241, 142243, 161577, 161579, 19335, 19336, 19339, 19340, 19865, 19866, 377181, 377183, 377408, 377412, 377414, 394809
HK	Department of Health Drug Office	06936, 06937, 30747
IE	Health Products Regulatory Authority	20346, 20354, 60399, 60410, 64874, 64877, 64878
IL	מִשְׂרַד הַבְּרִיאוּת	261, 8162, 8198
JP	医薬品医療機器総合機構	2646713M1136, 2646713N1123, 2646713Q1081
LT	Valstybinė vaistų kontrolės tarnyba	1002982, 1002983, 1004082, 1061047, 1069322, 1069323, 1078134, 1079565, 1083249, 1083250, 1084599, 1084883, 1085194, 1085584, 1088379, 1088999, 1093290
MT	Medicines Authority	MA192/04201, MA192/04202, MA192/04203, PI908/12001B, PI908/12002B
NG	Registered Drug Product Database	A4-1205
NL	Z-Index G-Standaard	12114669, 12355798, 12358061
NL	Z-Index G-Standaard, PRK	4863, 62782
PL	Rejestru Produktów Leczniczych	100018050, 100018066, 100254743, 100254980, 100266120, 100266976, 100451750
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64939001, W64941001, W64943001, W64943002
SG	Health Sciences Authority	04499P, 04933P, 04934P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522350711, 8699522356294, 8699522380725, 8699522386307, 8699522490738
ZA	Health Products Regulatory Authority	F/13.4.1/175, F/13.4.1/176, H/13.4.1/268